Compare SGMO & CXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGMO | CXE |
|---|---|---|
| Founded | 1995 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.2M | 118.2M |
| IPO Year | 2000 | N/A |
| Metric | SGMO | CXE |
|---|---|---|
| Price | $0.33 | $3.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 4.5M | 59.3K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.36% |
| EPS Growth | ★ 66.89 | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $36,567,000.00 | N/A |
| Revenue This Year | $4.79 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $53.57 |
| Revenue Growth | ★ 88.60 | N/A |
| 52 Week Low | $0.32 | $3.38 |
| 52 Week High | $0.88 | $3.88 |
| Indicator | SGMO | CXE |
|---|---|---|
| Relative Strength Index (RSI) | 36.95 | 41.51 |
| Support Level | N/A | $3.68 |
| Resistance Level | $0.56 | $3.80 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 15.03 | 15.73 |
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
Mfs High Income Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company's investment portfolio has shares from the industry Healthcare, Airports, and Secondary Schools.